Form 4 for NAGE Niagen Bioscience, Inc.
Accepted 2023-05-30 00:00:00 ET · period of report 2023-05-25 · accession 0001628280-23-020112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-30 | 2023-05-25 | NAGE | Rubin Steven D | Dir | P - Purchase | $1.46 | +7,000 | 7,000 | New | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-25 | P | A | 7,000 | $1.46 | 7,000 | D | — | — |